T7 Promoter in pET Plasmids Explained | Protein Expression

One common problem in protein expression is complete lack of protein production, which can occur if the protein is toxic to the host bacteria. Toxic proteins can kill bacteria before induction, preventing expression. The problem may also result from leaky expression (protein production before induction), which can be fatal for toxic proteins. For lac-based promoters, adding glucose (0.2-2%) to the growth medium inhibits expression by repressing the lac promoter. For T7-based systems, using BL21(DE3) pLysS bacteria, which express T7 lysozyme, can reduce leaky expression. When proteins are toxic to host bacteria, several strategies can improve expression. Using C41 or C43 bacterial strains, which have additional membrane proteins, can help bacteria survive toxic protein expression. Adding signal peptides can direct proteins to the periplasm, reducing toxicity. Using lower copy number plasmids reduces protein concentration. Codon optimization involves changing rare codons in a gene sequence to improve expression in the host organism. Rare codons can slow translation and reduce protein yield. The software can optimize codons for specific host organisms. However, codon optimization must be balanced with the need to maintain protein structure, as some rare codons may be important for proper protein folding. Different host strains have different codon pools, and choosing the appropriate host can improve expression without codon optimization. For protein expression in Erlenmeyer flasks, the culture volume should not exceed 50% of the flask capacity (50 ml in a 250 ml flask). Excessive volume reduces aeration, which is critical for bacterial growth and protein expression. The flask should be shaken to provide adequate oxygenation. Excessive agitation can cause foam formation, which may require antifoaming agents. Disulfide bonds form between cysteine residues and are important for proper protein folding. In the reducing environment of the bacterial cytoplasm, disulfide bonds cannot form correctly. To express proteins with disulfide bonds, researchers should use periplasmic expression (with signal peptides) or specialized strains like Origami, which have a more oxidizing cytoplasm. Proper disulfide bond formation is essential for protein stability and function. Chaperone-assisted protein folding can be achieved by co-transforming with chaperone plasmids or adding benzyl alcohol to the growth medium. Lower expression temperatures (15-25°C) can improve folding by reducing aggregation. Chromatography separates proteins based on their interactions with a stationary phase and a mobile phase. Affinity chromatography using His-tag exploits the nickel-binding property of histidine residues. The protein binds to nickel ions in the stationary phase. The column is washed to remove unbound proteins. The target protein is eluted using imidazole, which competes for nickel binding. Size exclusion chromatography separates proteins based on size. The column contains porous beads that proteins cannot enter. Large proteins pass through the column faster (elute first), while small proteins enter the pores and elute later. Ion exchange chromatography separates proteins based on charge. The stationary phase contains charged groups that bind proteins of opposite charge. A salt gradient (like NaCl) is used to elute proteins by competing for binding sites. Hydrophobic interaction chromatography separates proteins based on hydrophobicity. The stationary phase is hydrophobic, and proteins bind through hydrophobic interactions. A gradient of organic solvent (like acetonitrile) is used to elute proteins by reducing hydrophobic interactions. After purification, protein activity must be verified. For enzymes, zymography (zymogram) can be used, where the gel contains substrate. Active enzymes will degrade the substrate, creating clear zones on the gel. This assay confirms both protein presence and activity. Inactive proteins may indicate improper folding or degradation. Zymography is particularly useful for verifying enzyme function after purification. Western blotting detects specific proteins in a sample. Proteins are separated by SDS-PAGE, then transferred to a membrane (nitrocellulose or PVDF). The membrane is blocked with BSA or milk to prevent non-specific binding. Primary antibodies specific to the target protein are applied, followed by secondary antibodies conjugated to enzymes. The enzyme-substrate reaction produces a visible signal. Western blotting requires antibodies specific to the target protein. These can be purchased commercially or produced in animals. To produce antibodies, the target protein is injected into an animal (like a rabbit), and the animal's immune system produces antibodies against it. The antibodies are then purified from the animal's blood.

Successful expression of highly toxic genes in E. coli requires precise control of transcription and translation. Tightly regulated promoters like T7 lac show leaky expression, which can be mitigated using T7 lysozyme-expressing plasmids that inhibit transcription until after induction. The PPL promoter system offers tighter arabinose-controlled regulation. To prevent translation of leaky mRNA, antisense RNA binds to target mRNA forming secondary structures that block ribosome binding, while CRISPR interference uses guide RNAs for multi-site repression. Read-through transcription from strong promoters requires strong terminators like Rho-independent terminators (T1 and T2) between promoters and toxic genes. Plasmid copy number manipulation maintains low initial copies to prevent toxicity, then induces high copy numbers for improved yields using inducible promoters for replication proteins.

The PET system uses T7 phage elements for extremely strong protein expression. T7 RNA polymerase drives high-level transcription, but this can overwhelm cellular capacity (target protein comprising 50%+ of total cellular protein). The lac operon provides inducible control via IPTG addition, allowing dose-dependent tuning of expression levels. Special vectors exist for toxic proteins with leak-proof designs. This system represents a paradigmatic approach to maximizing heterologous protein production in bacteria.

To overcome lac promoter limitations, scientists developed advanced promoter systems: lacIq mutations increase LacI repressor production, reducing leaky expression; hybrid promoters combine tryptophan promoter strength with lac promoter inducibility (tac promoter); and two-step T7 expression systems use chromosomally integrated T7 RNA polymerase under lac promoter control, with T7 promoters on plasmids driving gene expression. Specialized E. coli strains address specific challenges: BL21(DE3) carries chromosomal T7 polymerase; BL21(DE3)pLysS produces T7 lysozyme to reduce expression of toxic proteins; BL21 CodonPlus(RIL) addresses codon bias by carrying extra tRNA genes; ArcticExpress produces cold-adapted chaperonins for proper folding; and Shuffle strains reduce disulfide bond reduction pathways for proper disulfide bond formation. Codon bias refers to preferential use of certain synonymous codons in different organisms, affecting translation efficiency.

BL21(DE3) serves as the standard host for T7 RNA polymerase-driven protein expression but suffers from leaky expression due to insufficient Lac repressor controlling both the T7 RNA polymerase promoter and target gene promoters. Solutions include high-control BL21(DE3) with overexpressed Lac repressor providing constant repression pools, and C41/C43(DE3) strains with reduced T7 RNA polymerase activity for better tolerance of toxic gene products. ClearColi represents an engineered solution for endotoxin-free applications by producing lipid IVa instead of complete LPS through deletion of seven biosynthetic genes plus a compensatory mutation. ClearColi BL21(DE3) maintains protein yields comparable to standard BL21(DE3) while showing 97-99% reduction in endotoxin activity. ClearColi K12 provides low-endotoxin plasmid production. These strains require higher salt LB Miller plates and grow at approximately 50% the rate of wild-type counterparts. Combined cloning-expression systems using XL1-Blue with rhamnose-inducible promoters eliminate the need to transfer plasmids between different host strains.

This video demonstrates the complete workflow for expressing and purifying His-tagged recombinant proteins from E. coli using immobilized metal affinity chromatography (IMAC). The process involves: (1) preparing LB media and sterilizing equipment via autoclaving; (2) growing starter cultures from transformed bacterial colonies, adding antibiotics at 1 μL/mL; (3) inoculating expression cultures and monitoring growth by measuring optical density (OD 0.4-0.8); (4) inducing protein expression with IPTG at 0.2 mM; (5) harvesting cells by centrifugation at 6000g for 30 min; (6) lysing cells using sonication in lysis buffer containing lysozyme, RNase, and protease inhibitors; (7) clearing lysates by centrifugation at 15,000g; (8) performing nickel affinity chromatography using either gravity columns or FPLC systems with wash and elution buffers containing imidazole; (9) analyzing purification fractions by SDS-PAGE; (10) concentrating and exchanging buffers using centrifugal filters and desalting columns; and (11) storing purified protein at -20°C or -80°C.

Recombinant protein production uses genetic engineering: cDNA encoding the protein is inserted into plasmid vectors and introduced into host cells. Cells synthesize the protein, often with added affinity tags (His tags, strep tags, GST, SUMO) for purification. Fusion partners improve solubility and folding. After cell lysis and centrifugation, the lysate contains the target protein mixed with contaminants. Affinity chromatography captures the tagged protein using complementary ligands on resin. Elution uses competitive agents (imidazole for His tags, biotin analogs for strep tags). Multiple strategies exist, with gradient versus stepwise elution affecting resolution.

After expression, cells are harvested by centrifugation to pellet the cells. The pellet is washed and resuspended in appropriate buffer, then frozen at -80°C. For lysis, bacterial cells require special treatment due to their tough cell walls: lysozyme breaks down the cell wall, sonication creates pressure waves that rupture cells, and DNAse degrades released DNA. The lysate is centrifuged to separate soluble proteins from insoluble debris. Affinity chromatography exploits specific interactions: His-tag binds nickel resin and eluted with imidazole; Strep-tag uses streptavidin-biotin interaction; GST binds glutathione resin; MBP binds amylose resin. Each tag requires a specific resin and elution method.

IMAC (Immobilized Metal Affinity Chromatography) is a protein purification technique where recombinant proteins are engineered with a His-tag (6-8 histidines in a row) that binds strongly to nickel ions immobilized on resin beads; the histidine residues act as polydentate chelators due to resonance stabilization in their imidazole rings, allowing the tagged protein to be selectively captured, washed, and then eluted using imidazole as a competitive ligand that displaces the protein from the nickel column.

The araBAD operon contains three genes (araB, araA, and araD) encoding enzymes for L-arabinose metabolism. The operon is regulated by the AraC protein, which binds to two operator sites and forms a DNA loop that blocks RNA polymerase. When L-arabinose is absent, AraC represses transcription by forming this loop. When L-arabinose is present, it binds to AraC, causing a conformational change that prevents loop formation and allows transcription. This DNA looping mechanism is a general principle of gene regulation in both prokaryotes and eukaryotes. The araBAD promoter is weaker than the T7 promoter, reducing metabolic burden on host cells and preventing cell death from overexpression.

The pBAD promoter uses the arabinose operon regulatory system. The AraC protein dimerizes and binds to operator sequences O2 and I1, blocking transcription. When arabinose is absent, the promoter is repressed. When arabinose is added, it binds to AraC causing a conformational change that causes the dimer to bind to I1 and I2 instead of O2 and I1, releasing the DNA from bending and allowing RNA polymerase access to transcribe the target gene.

Expression vector design must match host organism characteristics due to differences in protein synthesis machinery. E. coli uses Shine-Dalgarno sequences for ribosome binding, while eukaryotic hosts require Kozak consensus sequences. Common promoters include Lac-based systems (TAC hybrid promoter) and T7 promoter systems, with Lac uv5 mutants overcoming catabolite repression. Yeast systems (Pichia pastoris with AOX1 promoter, Saccharomyces cerevisiae with LAC4 promoter) efficiently produce glycosylated proteins with proper disulfide bonds. Baculovirus infects insect cells using strong promoters, offering safety advantages over mammalian viruses. Each system balances yield, post-translational modification capability, and production cost considerations.

The l-arabinose operon (araBAD) in E. coli is regulated by the AraC protein and cAMP-CAP complex through a sophisticated mechanism involving DNA looping and promoter competition; when arabinose is absent and glucose is present, AraC dimers form a DNA loop that blocks RNA polymerase access to the promoter, while in the presence of arabinose and low glucose, the activated CAP-cAMP complex recruits RNA polymerase to transcribe the operon, demonstrating how bacteria coordinate carbon source utilization through multi-level regulatory control.

This video explains how E. coli protein expression systems utilize inducible promoters (lac, ara, and trp) to control gene expression through regulatory mechanisms involving repressor proteins and inducers; the lac promoter uses allolactose/IPTG to relieve repression by causing conformational changes in the LacI repressor, while the ara promoter uses arabinose to trigger AraC dimer conformational changes that remove DNA looping, and the trp promoter uses tryptophan as a corepressor that dissociates when metabolized, demonstrating how different inducible systems provide varying levels of control over protein production.